SYNERGISTIC APOPTOTIC EFFECTS OF BORTEZOMIB AND METHYLSTAT ON DIFFERENT MULTIPLE MYELOMA CELL LINES

被引：0
|
作者：
Kaci, N. [1 ]
Kiraz, Y. [1 ]
Baran, Y. [1 ]
机构：
[1] Izmir Inst Technol, Mol Biol & Genet, Izmir, Turkey
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1850
引用
收藏
页码：730 / 731
页数：2
相关论文
共 50 条
  • [31] Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines
    Zeissig, Mara N.
    Hewett, Duncan R.
    Mrozik, Krzysztof M.
    Panagopoulos, Vasilios
    Wallington-Gates, Craig T.
    Spencer, Andrew
    Dold, Sandra M.
    Engelhardt, Monika
    Vandyke, Kate
    Zannettino, Andrew C. W.
    LEUKEMIA RESEARCH, 2024, 139
  • [32] Examination Of Ionizing Radiation, Bortezomib And GSK-3 Inhibition In Several Multiple Myeloma Cell Lines
    Silverman, J. S.
    Cho, H. J.
    Millman, S. E.
    Busino, L.
    Mazumder, A.
    Formenti, S. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S749 - S749
  • [33] Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines
    Ng, LT
    Chiang, LC
    Lin, YT
    Lin, CC
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2006, 34 (01): : 125 - 135
  • [34] The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-
    Morelli, Maria Beatrice
    Offidani, Massimo
    Alesiani, Francesco
    Discepoli, Giancarlo
    Liberati, Sonia
    Olivieri, Attilio
    Santoni, Matteo
    Santoni, Giorgio
    Leoni, Pietro
    Nabissi, Massimo
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (11) : 2534 - 2546
  • [35] Stromal cell derived IL6 inhibits the extrinsic apoptotic pathway in multiple myeloma cell lines
    Ackley, James C.
    McCachren, Samuel
    Lonial, Sagar
    Green, Damien J.
    Riddell, Stanley R.
    Hill, Geoffrey R.
    Dhodapkar, Madhav V.
    Boise, Lawrence H.
    CANCER RESEARCH, 2022, 82 (12)
  • [36] Bortezomib (PS-341) sensitizes multiple myeloma cell lines to etoposide-induced apoptosis.
    Zavrski, I
    Kaiser, M
    Rosche, M
    Heider, U
    Jakob, C
    Fleissner, C
    Possinger, K
    Sezer, O
    BLOOD, 2005, 106 (11) : 375B - 375B
  • [37] Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib
    Zhao, Yinghao
    Zhang, Kun
    Li, Guangquan
    Zhang, Xingyi
    Shi, Donglei
    PLOS ONE, 2015, 10 (05):
  • [38] The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment
    Santoni, Giorgio
    Amantini, Consuelo
    Maggi, Federica
    Marinelli, Oliviero
    Santoni, Matteo
    Morelli, Maria Beatrice
    BIOMOLECULES, 2022, 12 (01)
  • [39] Bortezomib inhibits mTOR pathway in multiple myeloma cell lines via induced expression of REDD1
    Decaux, Olivier
    Clement, Monique
    Magrangeas, Florence
    Lode, Laurence
    Charbonnel, Catherine
    Goureau, Wilfried
    Loiseau, Herve Avet
    Minvielle, Stephane
    BLOOD, 2007, 110 (11) : 78A - 78A
  • [40] Effects and mechanisms of bortezomib combined with arsenic trioxide on multiple myeloma
    Huang, Mingzhi
    Chen, Hongyan
    Zhuang, Yong
    Wu, Zhanyu
    Shang, Xianwen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 8388 - 8394
12345